I f you’re having trouble getting psoriatic arthritis (PsA) under control, it may be time to consider a biologic. “Biologics have been life-changing medications for people with psoriasis and psoriatic ...
INCHEON, South Korea--(BUSINESS WIRE)--A new post-hoc analysis of a pivotal phase III randomised controlled clinical trial shows that the subcutaneous (SC) formulation of infliximab, Remsima ® (CT-P13 ...
Credit: Fresenius Kabi. Tyenne is indicated for treatment of moderately to severely active rheumatoid arthritis, giant cell arteritis, active polyarticular juvenile idiopathic arthritis, and active ...
Please provide your email address to receive an email when new articles are posted on . Monoclonal antibodies decrease inflammation in the immune system by binding to ...
Truxima is a biosimilar version of the brand-name drug Rituxan. Biosimilars tend to be less expensive than their brand-name versions. Doctors prescribe Truxima to treat conditions such as rheumatoid ...
Orencia (abatacept) and Humira (adalimumab) are prescription drugs used to treat inflammatory arthritis. They have other uses as well. Both drugs can be given as an injection under the skin. This ...
Living with psoriatic arthritis often means juggling symptoms such as skin plaques, joint pain, and fatigue while exploring different treatments to find what works best for you. Starting a new ...
Organon has acquired regulatory and commercial rights in the United States from Biogen for Tofidence, a biosimilar to Actemra for intravenous infusion. Tofidence, the first approved tocilizumab ...
A United States of America – trained physician Dr. Helen Mbakwe, has unveiled the country’s first outpatient infusion and arthritis management center in Abuja. Mbakwe said that the newly launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results